Clarivate Plc (NYSE:CLVT – Get Free Report) has earned an average rating of “Hold” from the six brokerages that are covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $7.10.
A number of brokerages recently weighed in on CLVT. William Blair downgraded shares of Clarivate from an “outperform” rating to a “market perform” rating in a report on Wednesday, November 6th. Barclays lowered their price objective on shares of Clarivate from $5.00 to $4.00 and set an “underweight” rating on the stock in a research note on Thursday, November 7th. Finally, Royal Bank of Canada reiterated a “sector perform” rating and issued a $6.00 target price on shares of Clarivate in a research note on Thursday.
Read Our Latest Analysis on CLVT
Hedge Funds Weigh In On Clarivate
Clarivate Stock Up 0.1 %
Shares of CLVT stock opened at $4.85 on Thursday. The firm’s fifty day moving average price is $5.12 and its two-hundred day moving average price is $5.80. The company has a current ratio of 0.87, a quick ratio of 0.88 and a debt-to-equity ratio of 0.88. Clarivate has a 1 year low of $4.22 and a 1 year high of $9.07. The firm has a market capitalization of $3.35 billion, a P/E ratio of -5.05 and a beta of 1.17.
Clarivate declared that its Board of Directors has initiated a share repurchase plan on Monday, December 16th that permits the company to repurchase $500.00 million in outstanding shares. This repurchase authorization permits the company to repurchase up to 12.8% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company’s board of directors believes its stock is undervalued.
Clarivate Company Profile
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.
Recommended Stories
- Five stocks we like better than Clarivate
- Pros And Cons Of Monthly Dividend Stocks
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- DuPont’s Electronics Spinoff: The Start of Something Big
- Insider Selling Explained: Can it Inform Your Investing Choices?
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Receive News & Ratings for Clarivate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clarivate and related companies with MarketBeat.com's FREE daily email newsletter.